Literature DB >> 10825189

Mad1 function is regulated through elements within the carboxy terminus.

G Barrera-Hernandez1, C M Cultraro, S Pianetti, S Segal.   

Abstract

Myc and Mad are basic helix-loop-helix leucine zipper (bHLH-LZ) proteins that heterodimerize with Max to bind DNA and thereby influence the transcription of Myc-responsive genes. Myc-Max dimers transactivate whereas Mad-Max-mSin3 complexes repress Myc-mediated transcriptional activation. We have previously shown that the N-terminal mSin3 binding domain and the centrally located bHLH-LZ are required for Mad1 to function during a molecular switch from proliferation to differentiation. Here we demonstrate that the carboxy terminus (CT) of Mad1 contains previously unidentified motifs necessary for the regulation of Mad1 function. We show that removal of the last 18 amino acids of Mad1 (region V) abolishes the growth-inhibitory function of the protein and the ability to reverse a Myc-imposed differentiation block. Moreover, deletion of region V results in a protein that binds DNA weakly and no longer represses Myc-dependent transcriptional activation. In contrast, deletion of the preceding 24 amino acids (region IV) together with region V restores DNA binding and transcriptional repression, suggesting a functional interplay between these two regions. Furthermore, phosphorylation within region IV appears to mediate this interplay. These findings indicate that novel regulatory elements are present in the Mad1 CT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825189      PMCID: PMC85793          DOI: 10.1128/MCB.20.12.4253-4264.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.

Authors:  C D Reddy; P Dasgupta; P Saikumar; H Dudek; F J Rauscher; E P Reddy
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

2.  A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.

Authors:  D E Ayer; R N Eisenman
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

3.  Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.

Authors:  D E Ayer; L Kretzner; R N Eisenman
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

4.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

5.  Differential patterns of DNA binding by myc and max proteins.

Authors:  E V Prochownik; M E VanAntwerp
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

6.  Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.

Authors:  W Gu; K Cechova; V Tassi; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62.

Authors:  S Gupta; A Seth; R J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Oncogenic activity of the c-Myc protein requires dimerization with Max.

Authors:  B Amati; M W Brooks; N Levy; T D Littlewood; G I Evan; H Land
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

9.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.

Authors:  K Bousset; M Henriksson; J M Lüscher-Firzlaff; D W Litchfield; B Lüscher
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

View more
  3 in total

1.  Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor.

Authors:  Volker Ellenrieder; Jin-San Zhang; Joanna Kaczynski; Raul Urrutia
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

2.  The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription.

Authors:  Chao-Kai Chou; Dung-Fang Lee; Hui-Lung Sun; Long-Yuan Li; Chun-Yi Lin; Wei-Chien Huang; Jung-Mao Hsu; Hsu-Ping Kuo; Hirohito Yamaguchi; Ying-Nai Wang; Mo Liu; Hsin-Yi Wu; Pao-Chi Liao; Chia-Jui Yen; Mien-Chie Hung
Journal:  Mol Carcinog       Date:  2009-11       Impact factor: 4.784

3.  Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation.

Authors:  Yiyu Zhang; Aleksandra Dakic; Renxiang Chen; Yuhai Dai; Richard Schlegel; Xuefeng Liu
Journal:  Oncotarget       Date:  2017-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.